183 related articles for article (PubMed ID: 36384580)
1. WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC.
Wang R; Zhao J; Jin J; Tian Y; Lan L; Wang X; Zhu L; Wang J
Lipids Health Dis; 2022 Nov; 21(1):121. PubMed ID: 36384580
[TBL] [Abstract][Full Text] [Related]
2. Overexpression CPT1A reduces lipid accumulation via PPARα/CD36 axis to suppress the cell proliferation in ccRCC.
Yang H; Zhao H; Ren Z; Yi X; Zhang Q; Yang Z; Kuang Y; Zhu Y
Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(2):220-231. PubMed ID: 35130611
[TBL] [Abstract][Full Text] [Related]
3. CPT2-mediated fatty acid oxidation inhibits tumorigenesis and enhances sorafenib sensitivity via the ROS/PPARγ/NF-κB pathway in clear cell renal cell carcinoma.
Zeng K; Li Q; Song G; Chen B; Luo M; Miao J; Liu B
Cell Signal; 2023 Oct; 110():110838. PubMed ID: 37541641
[TBL] [Abstract][Full Text] [Related]
4. HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism.
Du W; Zhang L; Brett-Morris A; Aguila B; Kerner J; Hoppel CL; Puchowicz M; Serra D; Herrero L; Rini BI; Campbell S; Welford SM
Nat Commun; 2017 Nov; 8(1):1769. PubMed ID: 29176561
[TBL] [Abstract][Full Text] [Related]
5. WY-14643 Regulates CYP1B1 Expression through Peroxisome Proliferator-Activated Receptor α-Mediated Signaling in Human Breast Cancer Cells.
Hwang YP; Won SS; Jin SW; Lee GH; Pham TH; Choi JH; Kang KW; Jeong HG
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775380
[TBL] [Abstract][Full Text] [Related]
6. Hepatic peroxisome proliferator-activated receptor alpha mediates the major metabolic effects of Wy-14643.
Li G; Brocker CN; Xie C; Yan T; Noguchi A; Krausz KW; Xiang R; Gonzalez FJ
J Gastroenterol Hepatol; 2018 May; 33(5):1138-1145. PubMed ID: 29141109
[TBL] [Abstract][Full Text] [Related]
7. PPARalpha activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes.
Edvardsson U; Ljungberg A; Lindén D; William-Olsson L; Peilot-Sjögren H; Ahnmark A; Oscarsson J
J Lipid Res; 2006 Feb; 47(2):329-40. PubMed ID: 16282640
[TBL] [Abstract][Full Text] [Related]
8. Toxic effects of fumonisin in mouse liver are independent of the peroxisome proliferator-activated receptor alpha.
Voss KA; Liu J; Anderson SP; Dunn C; Miller JD; Owen JR; Riley RT; Bacon CW; Corton JC
Toxicol Sci; 2006 Jan; 89(1):108-19. PubMed ID: 16221962
[TBL] [Abstract][Full Text] [Related]
9. Chronic Treatment With WY-14643 Induces Tumorigenesis and Triglyceride Accumulation in Mouse Livers.
Yang J; Fan S; Zhang Y; Huang M; Gao Y; Bi H
Drug Metab Dispos; 2022 Dec; 50(12):1464-1471. PubMed ID: 36184081
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway.
Zhang N; Chu ES; Zhang J; Li X; Liang Q; Chen J; Chen M; Teoh N; Farrell G; Sung JJ; Yu J
Oncotarget; 2014 Sep; 5(18):8330-40. PubMed ID: 25327562
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
12. Short communication: the pharmacological peroxisome proliferator-activated receptor α agonist WY-14,643 increases expression of novel organic cation transporter 2 and carnitine uptake in bovine kidney cells.
Zhou X; Wen G; Ringseis R; Eder K
J Dairy Sci; 2014; 97(1):345-9. PubMed ID: 24210485
[TBL] [Abstract][Full Text] [Related]
13. Differential action of 13-HPODE on PPARalpha downstream genes in rat Fao and human HepG2 hepatoma cell lines.
König B; Eder K
J Nutr Biochem; 2006 Jun; 17(6):410-8. PubMed ID: 16216487
[TBL] [Abstract][Full Text] [Related]
14. PPARα regulates tumor cell proliferation and senescence via a novel target gene carnitine palmitoyltransferase 1C.
Chen Y; Wang Y; Huang Y; Zeng H; Hu B; Guan L; Zhang H; Yu AM; Johnson CH; Gonzalez FJ; Huang M; Bi H
Carcinogenesis; 2017 Apr; 38(4):474-483. PubMed ID: 28334197
[TBL] [Abstract][Full Text] [Related]
15. Ror1 promotes PPARα-mediated fatty acid metabolism in astrocytes.
Tanaka Y; Minami Y; Endo M
Genes Cells; 2023 Apr; 28(4):307-318. PubMed ID: 36811220
[TBL] [Abstract][Full Text] [Related]
16. PPARα mediates sunitinib resistance via NF-κB activation in clear cell renal cell carcinoma.
Aimudula A; Nasier H; Yang Y; Zhang R; Lu P; Hao J; Bao Y
Int J Clin Exp Pathol; 2018; 11(5):2389-2400. PubMed ID: 31938351
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A.
Cheng Y; Dharancy S; Malapel M; Desreumaux P
World J Gastroenterol; 2005 Dec; 11(48):7591-6. PubMed ID: 16437683
[TBL] [Abstract][Full Text] [Related]
18. 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha.
Fang X; Hu S; Xu B; Snyder GD; Harmon S; Yao J; Liu Y; Sangras B; Falck JR; Weintraub NL; Spector AA
Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H55-63. PubMed ID: 16113065
[TBL] [Abstract][Full Text] [Related]
19. PPARα regulates the expression of human arylacetamide deacetylase involved in drug hydrolysis and lipid metabolism.
Morikawa T; Fukami T; Gotoh-Saito S; Nakano M; Nakajima M
Biochem Pharmacol; 2022 May; 199():115010. PubMed ID: 35314168
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte peroxisome proliferator-activated receptor α regulates bile acid synthesis and transport.
Xie C; Takahashi S; Brocker CN; He S; Chen L; Xie G; Jang K; Gao X; Krausz KW; Qu A; Levi M; Gonzalez FJ
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Oct; 1864(10):1396-1411. PubMed ID: 31195146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
